Metastatic Colorectal Cancer: JNJ-89402638 Study

We are testing a new drug, JNJ-89402638, for patients with metastatic colorectal cancer. This study aims to evaluate its safety and how it may help in treating this advanced stage of cancer.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Medical Oncology
Barcelona, Spain
Hospital Universitario Hm Sanchinarro
Medical Oncology
Chamartín, Spain
Hospital Universitario 12 De Octubre
Medical Oncology
Madrid, Spain

Sponsor: Janssen Cilag International
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.